ACADIA Pharmaceuticals, Inc. (ACAD)
20.92
-0.48
(-2.24%)
USD |
NASDAQ |
May 18, 13:17
ACADIA Pharmaceuticals Research and Development Expense (Quarterly) : 76.87M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 209.48M |
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| BioMarin Pharmaceutical, Inc. | 178.80M |
| MannKind Corp. | 17.23M |
| Regeneron Pharmaceuticals, Inc. | 1.420B |